Literature DB >> 8793401

Staphylococcus lugdunensis as a cause of abscesses in the perineal area.

V Ortiz de la Tabla1, F Gutiérrez-Rodero, C Martín, A Zorraquino, I Belinchón.   

Abstract

The first two patients with skin infections in the perineal area due to Staphylococcus lugdunensis are described. One had an abscess of the Bartholin gland, and the other presented with several cutaneous abscesses in the pubic area, which had a prolonged and recurrent clinical course despite appropriate antibiotic treatment. This report emphasizes the pathogenic role of Staphylococcus lugdunensis and the importance of identifying coagulase-negative staphylococci to species level in some instances.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8793401     DOI： 10.1007/bf01690099

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  10 in total

1.  Delta-like haemolysin produced by Staphylococcus lugdunensis.

Authors:  F Vandenesch; M J Storrs; F Poitevin-Later; J Etienne; P Courvalin; J Fleurette
Journal:  FEMS Microbiol Lett       Date:  1991-02       Impact factor: 2.742

2.  Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection.

Authors:  T E Herchline; L W Ayers
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

3.  Staphylococcus lugdunensis arthritis: a complication of arthroscopy.

Authors:  E Palazzo; J Pierre; N Besbes
Journal:  J Rheumatol       Date:  1992-02       Impact factor: 4.666

4.  [Sepsis caused by Staphylococcus lugdunensis].

Authors:  P López; C Fornós; M Galera; F Rosell
Journal:  Enferm Infecc Microbiol Clin       Date:  1992-12       Impact factor: 1.731

5.  Non-puerperal breast infections due to Staphylococcus lugdunensis.

Authors:  B Lina; F Vandenesch; M E Reverdy; T Greenland; J Fleurette; J Etienne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-08       Impact factor: 3.267

6.  Staphylococcus lugdunensis as a cause of breast abscess.

Authors:  D J Waghorn
Journal:  Clin Infect Dis       Date:  1994-10       Impact factor: 9.079

7.  Hemolysins and other characteristics that help differentiate and biotype Staphylococcus lugdunensis and Staphylococcus schleiferi.

Authors:  G A Hébert
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

Review 8.  Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review.

Authors:  F Vandenesch; J Etienne; M E Reverdy; S J Eykyn
Journal:  Clin Infect Dis       Date:  1993-11       Impact factor: 9.079

9.  Staphylococcus lugdunensis endocarditis.

Authors:  R Shuttleworth; W D Colby
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

10.  Clinical isolates of Staphylococcus lugdunensis and S. schleiferi: bacteriological characteristics and susceptibility to antimicrobial agents.

Authors:  J Fleurette; M Bès; Y Brun; J Freney; F Forey; M Coulet; M E Reverdy; J Etienne
Journal:  Res Microbiol       Date:  1989-02       Impact factor: 3.992
  10 in total
  4 in total

1.  Staphylococcus lugdunensis infections: high frequency of inguinal area carriage.

Authors:  N van der Mee-Marquet; A Achard; L Mereghetti; A Danton; M Minier; R Quentin
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

2.  Synergistic hemolytic activity of Staphylococcus lugdunensis is mediated by three peptides encoded by a non-agr genetic locus.

Authors:  B Donvito; J Etienne; L Denoroy; T Greenland; Y Benito; F Vandenesch
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

Review 3.  From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis.

Authors:  Kristi L Frank; José Luis Del Pozo; Robin Patel
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

4.  Abscesses and wound infections due to Staphylococcus lugdunensis: report of 16 cases.

Authors:  N Papapetropoulos; M Papapetropoulou; A Vantarakis
Journal:  Infection       Date:  2012-12-16       Impact factor: 3.553
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.